BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring…
Why BioNTech Stock Soared Today
Bristol Myers Squibb just agreed to shower BioNTech with cash. BioNTech (BNTX 20.29%), one of the companies made…